ARTICLES BY THIS AUTHOR
- 3/15/2021
Lupin debuts authorized generic of Alinia
Nitazoxanide tablets had a market value of $56 million, according to IQVIA January 2021 data. - 3/15/2021
Gilead, Merck launch partnership to develop long-acting HIV treatments
Gilead and Merck will co-develop and co-commercialize long- acting HIV treatments that combine Gilead’s lenacapavir, and Merck’s islatravir. - 3/15/2021
Fresenius Kabi intros generic Foscavir
Fresenius Kabi is launching the first to market generic for Foscavir, a treatment for immune-compromised patients. - 3/11/2021
Health Mart's Nancy Lyons highlights pharmacy's role in ending HIV during virtual event
Health Mart’s Nancy Lyons emphasized the ways independent community pharmacies can assist in ending the HIV epidemic during a virtual event held by the Presidential Advisory Council on HIV/AIDS. - 3/11/2021
CVS Health now offering COVID-19 vaccines in 29 states and Puerto Rico
CVS Health now is administering vaccines in nearly 1,200 stores across 29 states and Puerto Rico. - 3/10/2021
Biden to announce additional buy of 100M J&J COVID-19 vaccine doses
President Biden is expected to announce that he is directing the Department of Health and Human Services to purchase an additional 100 million does of Johson & Johnson's COVID-19 vaccine. - 3/10/2021
NACDS announces speakers for upcoming 2021 virtual annual meeting
Former Food and Drug Administration commissioner Scott Gottlieb and presidential historian and author Jon Meacham will be featured speakers at the 2021 NACDS virtual meeting's Business Programs in April. - 3/10/2021
Xiromed intros 2 generics
The Insud Pharmaceuticals division is launching its generics of Alkeran and Prometrium, which had market sizes of $20.4 million and $74.8 million for the year ended December 2020, according to IQVIA data. - 3/5/2021
Unichem receives FDA OK for generic Tenex
Unichem's generic Tenex provides a treatment for the management of hypertension. - 3/9/2021
NACDS' Anderson discusses INFORM Consumers Act in op-ed
In a Morning Consult op-ed, Steve Anderson, president and CEO of the National Association of Chain Drug Stores, welcomed the reintroduction of The INFORM Consumers Act and called on Congress to keep customers safe from organized retail crime.